Vertex Pharmaceuticals Inc / Ma

MASSACHUSETTS FINANCIAL SERVICES CO /MA/ VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/22/2026

Shares

211,934

Value ($000)

96,082

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/22/2026	96,082	0.0%	211,934	12/31/2025
2025 Q3	10/29/2025	197,058	0.1%	503,160	9/30/2025
2025 Q2	8/8/2025	571,794	0.2%	1,284,354	6/30/2025
2025 Q1	5/2/2025	981,716	0.3%	2,024,908	3/31/2025
2024 Q4	2/12/2025	921,578	0.3%	2,288,498	12/31/2024
2024 Q3	11/12/2024	1,351,385	0.4%	2,905,705	9/30/2024
2024 Q2	8/9/2024	1,287,111	0.4%	2,746,012	6/30/2024
2024 Q1	5/14/2024	1,172,179	0.4%	2,804,188	3/31/2024
2023 Q4	2/8/2024	1,475,303	0.5%	3,625,802	12/31/2023
2023 Q3	11/8/2023	1,353,332	0.5%	3,891,794	9/30/2023
2023 Q2	8/9/2023	1,386,920	0.5%	3,941,121	6/30/2023
2023 Q1	5/10/2023	1,274,468	0.4%	4,045,031	3/31/2023
2022 Q4	2/13/2023	1,187,335	0.4%	4,111,555	12/31/2022
2022 Q3	11/9/2022	1,258,552	0.5%	4,346,731	9/30/2022
2022 Q2	8/9/2022	1,223,563	0.4%	4,342,112	6/30/2022
2022 Q1	5/11/2022	917,351	0.3%	3,515,153	3/31/2022
2021 Q4	2/10/2022	701,550	0.2%	3,194,678	12/31/2021
2021 Q3	11/10/2021	571,241	0.2%	3,149,240	9/30/2021
2021 Q2	8/13/2021	635,897	0.2%	3,153,787	6/30/2021
2021 Q1	5/13/2021	613,858	0.2%	2,856,616	3/31/2021
2020 Q4	5/12/2021	622,546	0.2%	2,634,109	12/31/2020
2020 Q3	11/12/2020	517,071	0.2%	1,900,157	9/30/2020
2020 Q2	11/20/2020	524,962	0.2%	1,808,281	6/30/2020
2020 Q1	11/20/2020	291,914	0.1%	1,226,786	3/31/2020
2019 Q4	11/25/2020	246,018	0.1%	1,123,628	12/31/2019
2019 Q3	11/20/2020	206,682	0.1%	1,219,940	9/30/2019
2014 Q1	5/13/2014	5,566	0.0%	78,710	3/31/2014
2013 Q4	2/12/2014	5,955	0.0%	80,150	12/31/2013